News

AI – the acronym on everyone’s lips, and rightly so, as it has a huge variety of potential applications in pharma. In light of this, Pharmaceutical Market Europe (PME) asked Ed Corbett for a special report piece, to consider AI and how pharma should navigate this burgeoning technology.

To read the full article click here or download this article using the button above.

If you want to learn more about AI in pharma our white paper on the topic gives great insight into what pharma should do about AI or for an insider’s perspective our interview with Don Van Dyke, COO of Cloud Pharmaceuticals, looks at what the potential of AI is and whether the hype is justified

To view the contents of this post, please submit your email address and you will gain access to all posts on our web site...






Click here if you would like to receive emails from us. Read our privacy policy

To receive details of new white papers and events please enter your details below

Click here if you would like to receive emails from us. Read our privacy policy

Newsletter Signup